hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes

Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells

Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells

[Roles of Newcastle disease virus in human acute monocytic leukemia in vitro and in vivo]

Dendritic cell vaccination against ovarian cancer–tipping the Treg/TH17 balance to therapeutic advantage?

Oncolytic virus-initiated protective immunity against prostate cancer